STOCK TITAN

Labcorp Launches MyLabcorp™, a New AI-Powered Mobile App Designed to Help Consumers Understand Lab Results and Track Health Trends Over Time

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags
AI

Labcorp (NYSE: LH) launched MyLabcorp™, an AI-powered mobile app that helps consumers understand lab results and track health trends over time. The HIPAA-compliant app integrates Labcorp test results, OpenAI-powered explanations, and clinically reviewed educational content in a secure, personalized experience.

Users can review trends, chat with an AI assistant, access health education, schedule appointments, shop for tests, and manage billing. According to Labcorp, MyLabcorp is now available in the Apple App Store and Google Play Store, with additional features planned.

Loading...
Loading translation...

AI-generated analysis. Not financial advice.

Positive

  • None.

Negative

  • None.

News Market Reaction – LH

+0.61%
1 alert
+0.61% News Effect

On the day this news was published, LH gained 0.61%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Consumers valuing AI: 55% Using AI for lab results: 41% Using AI for ranges: 35%
3 metrics
Consumers valuing AI 55% Survey share viewing AI as important for understanding healthcare information
Using AI for lab results 41% Survey share already using AI to interpret lab results
Using AI for ranges 35% Survey share using AI to understand test ranges

Market Reality Check

Price: $260.06 Vol: Volume 522,909 is 0.7x th...
normal vol
$260.06 Last Close
Volume Volume 522,909 is 0.7x the 20-day average of 747,229, indicating subdued trading ahead of this AI app launch. normal
Technical Shares at $253.69 are trading below the 200-day MA of $268.56 and about 13.63% under the 52-week high of $293.72.

Peers on Argus

LH slipped 0.74% while key peers like DGX, NTRA, WAT, and IQV posted modest gain...

LH slipped 0.74% while key peers like DGX, NTRA, WAT, and IQV posted modest gains (up to 1.34%), and MTD declined 1.9%, pointing to stock‑specific softness rather than a unified sector move.

Previous AI Reports

2 past events · Latest: Apr 14 (Positive)
Same Type Pattern 2 events
Date Event Sentiment Move Catalyst
Apr 14 AI data platform Positive +1.8% Launched AI-powered real-world data platform for Alzheimer’s research with AWS, Datavant.
Jul 30 AI test finder Positive +0.8% Introduced Test Finder generative AI tool with AWS to simplify lab test search.
Pattern Detected

Past AI-related announcements for Labcorp generated modest positive next-day moves, suggesting the market has historically reacted favorably but not explosively to similar innovation news.

Recent Company History

Over the last year, Labcorp has repeatedly highlighted AI initiatives. On Apr 14, 2026, it launched an AI-powered real-world data platform for Alzheimer’s research, and on Jul 30, 2025, it introduced the Test Finder generative AI tool with AWS. Those events saw next‑day moves of 1.78% and 0.84%, respectively. Today’s MyLabcorp™ consumer AI app continues this strategy of embedding AI across workflows, extending from provider tools to patient-facing experiences.

Historical Comparison

+1.3% avg move · In the past two AI-tagged announcements, Labcorp’s stock moved an average of 1.31% the next day. The...
AI
+1.3%
Average Historical Move AI

In the past two AI-tagged announcements, Labcorp’s stock moved an average of 1.31% the next day. The MyLabcorp™ AI app fits the same digital-innovation pattern aimed at using AI to interpret diagnostic data.

AI efforts show progression from provider tools (Test Finder) to research platforms and now a consumer-facing app for lab result interpretation.

Market Pulse Summary

This announcement highlights Labcorp’s continued push to embed AI into its offerings, this time via ...
Analysis

This announcement highlights Labcorp’s continued push to embed AI into its offerings, this time via the MyLabcorp™ consumer app that combines lab results with AI-generated explanations. Survey data showing 55% of consumers view AI as important for understanding healthcare information underscores the demand it targets. In context with prior AI initiatives for providers and researchers, observers may watch adoption levels, feature expansion, and how these tools complement Labcorp’s broader diagnostics and biopharma platforms.

Key Terms

AI-powered, AI-enabled, HIPAA‑compliant, cardiometabolic
4 terms
AI-powered technical
"announced the launch of MyLabcorp™, an AI-powered mobile app that brings together"
"AI-powered" describes technology that uses artificial intelligence to perform tasks, make decisions, or analyze information automatically. It’s similar to having a highly skilled assistant that can learn from data, recognize patterns, and improve over time, helping to make processes faster and more accurate. For investors, this means better insights and more efficient operations, potentially leading to smarter investment choices.
AI-enabled technical
"MyLabcorp™, an AI-powered mobile app that brings together lab results, AI-enabled features"
AI-enabled describes a product, service, or process that uses artificial intelligence—software that learns from data and makes decisions or predictions—as a core feature rather than a minor add-on. For investors it matters because AI-enabled offerings can boost productivity, lower costs or unlock new revenue streams; like adding a smart autopilot to a routine task, they can change a company's growth potential and competitive edge while also bringing higher upfront investment needs and distinct regulatory or ethical risks.
HIPAA‑compliant regulatory
"Secure, trusted experience – A HIPAA‑compliant platform built to protect personal"
hipaa-compliant means a company follows U.S. rules designed to protect people’s private health information by using security controls, access limits, and policies that prevent unauthorized use or disclosure. For investors, compliance signals lower legal and financial risk—like keeping sensitive records in a locked safe with strict key rules—reducing the chance of costly fines, lawsuits, data breaches, and damage to reputation that can hurt revenue and valuation.
cardiometabolic medical
"information across key health areas, including cardiometabolic health, mental health, digestion"
Cardiometabolic describes health conditions that affect the heart and the body’s metabolism—most commonly heart disease, high blood pressure, type 2 diabetes and obesity—that often occur together and share common causes. Investors care because these linked conditions drive large, predictable demand for drugs, medical devices and long-term care, and changes in treatment options, guidelines or costs can materially affect healthcare company revenues and government spending much like a problem in an engine and its fuel system impacts the whole vehicle.

AI-generated analysis. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
  • MyLabcorp connects lab results, educational content and AI-enabled features in a secure, personalized mobile experience
  • Leverages OpenAI models designed to help users understand their results, ask questions and identify patterns over time

BURLINGTON, N.C., May 20, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the launch of MyLabcorp, an AI-powered mobile app that brings together lab results, AI-enabled features and clinical guideline-based content in a secure, personalized mobile experience. The app is designed to give users additional context about their health and support more informed conversations with healthcare providers.

Meeting Demand for Clearer Health Information
As healthcare becomes increasingly consumer-driven, individuals are turning to AI tools to help interpret health information, from understanding lab results to determining next steps in care. According to a Labcorp survey, more than half of consumers (55%) view AI as important for understanding healthcare information, with many already using it to interpret lab results (41%) and understand test ranges (35%). However, many AI tools answer questions in isolation without broader clinical context. MyLabcorp aims to address this gap by enabling users to view their Labcorp test results alongside relevant educational content and AI-generated explanations based on available data over time.

"Consumers are increasingly turning to AI to help them make sense of their health, but trust and clinical context matter," said Amy Summy, EVP and chief marketing officer at Labcorp. "By bringing together Labcorp's deep scientific expertise with AI, MyLabcorp is designed to help individuals move beyond isolated results to gain deeper insights into their health and support more informed conversations with their healthcare providers."

A More Connected, Intuitive Way to Understand Health
Key features of MyLabcorp include:

  • Lab results over time – Users have access to their Labcorp test results in a mobile-friendly view that tracks trends over time.
  • AIenabled insights – Users can chat with an AI assistant for real‑time, personalized explanations of lab results and lifestyle considerations based on available Labcorp test data. MyLabcorp's AI capabilities are powered in part by OpenAI's advanced reasoning models, enabling more natural, conversational interactions tailored to each user.
  • Health education content – Users can explore clinically reviewed, guideline-based information across key health areas, including cardiometabolic health, mental health, digestion, kidney function and sexual health, integrated with lab results to show trends and provide additional context.
  • Lab services and support – Users can view and schedule appointments, locate patient service centers, access results, shop for tests and manage billing.
  • Secure, trusted experience – A HIPAA‑compliant platform built to protect personal health information and user data.

"At Labcorp, we're investing in advanced technology and AI to make diagnostic insights more accessible, personalized and actionable, improving how people understand and manage their health," said Bola Oyegunwa, Ph.D., EVP and chief information and technology officer at Labcorp. "MyLabcorp reflects this approach by combining Labcorp's scientific expertise with OpenAI's models to help individuals better understand their results and identify patterns over time, all within a secure, trusted environment."

Availability of MyLabcorp1
MyLabcorp is now available in the Apple App Store and Google Play Store with additional features rolling out on an ongoing basis.

To learn more, visit https://www.labcorp.com/patients/mylabcorp

About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's nearly 71,000 employees serve clients in approximately 100 countries, provided support for more than 85% of the new drugs and therapeutic products approved by the FDA in 2025 and performed more than 750 million tests for patients around the world. Learn more at www.labcorp.com.

Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements, including, but not limited to, statements with respect to the expected utility and benefits of MyLabcorp.

Each of the forward-looking statements is subject to change based on various important factors, many of which are beyond the company's control. These factors, in some cases, have affected and in the future (together with other factors) could affect the company's ability to implement the company's business strategy, and actual results could differ materially from those suggested by these forward-looking statements. As a result, readers are cautioned not to place undue reliance on any of the forward-looking statements.

The company has no obligation to provide any updates to these forward-looking statements even if its expectations change. All forward-looking statements are expressly qualified in their entirety by this cautionary statement. Further information on potential factors, risks and uncertainties that could affect operating and financial results is included in the company's most recent Annual Report on Form 10-K under the heading RISK FACTORS and in the company's other filings with the SEC. The information in this press release should be read in conjunction with a review of the company's filings with the SEC including the information in the company's most recent Annual Report on Form 10-K under the heading "MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS."

____________________________

1

MyLabcorp is designed to support understanding and wellness and does not provide medical diagnoses or treatment recommendations. Always consult a qualified healthcare professional with medical questions or concerns.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/labcorp-launches-mylabcorp-a-new-ai-powered-mobile-app-designed-to-help-consumers-understand-lab-results-and-track-health-trends-over-time-302777006.html

SOURCE Labcorp

FAQ

What is Labcorp's MyLabcorp™ app (NYSE: LH) and what does it do?

MyLabcorp™ is an AI-powered mobile app that helps users understand Labcorp lab results and track health trends over time. According to Labcorp, it combines test results, AI-generated explanations, and guideline-based health education to support more informed conversations with healthcare providers.

How does the MyLabcorp™ app from Labcorp (LH) use AI to explain lab results?

MyLabcorp™ uses an AI assistant to provide real-time, personalized explanations of Labcorp lab results and lifestyle considerations. According to Labcorp, its capabilities are powered in part by OpenAI's advanced reasoning models, enabling natural, conversational responses based on available test data over time.

Is Labcorp's MyLabcorp™ app secure and HIPAA compliant for patient data?

MyLabcorp™ is described as a HIPAA-compliant platform designed to protect personal health information and user data. According to Labcorp, the app delivers AI-enabled insights within a secure, trusted environment that integrates lab results, education content, and service tools for patients.

What health features does Labcorp's MyLabcorp™ (NYSE: LH) offer to consumers?

MyLabcorp™ offers trend views of Labcorp lab results, AI-enabled insights, and clinically reviewed health education content. According to Labcorp, users can also schedule appointments, find patient service centers, access results, shop for tests, and manage billing in one mobile-friendly experience.

When and where is Labcorp's MyLabcorp™ app available for download?

MyLabcorp™ is now available for download in the Apple App Store and Google Play Store. According to Labcorp, the company plans to roll out additional features on an ongoing basis, expanding the app’s AI-enabled insights and integrated health management tools over time.

What types of health topics are covered in Labcorp's MyLabcorp™ educational content?

MyLabcorp™ includes clinically reviewed, guideline-based information on cardiometabolic health, mental health, digestion, kidney function, and sexual health. According to Labcorp, this content is integrated with lab results to show trends and provide additional context for users managing different aspects of their health.